Lupin gets USFDA nod for generic drug to treat seizures
Lupin gets USFDA nod for generic drug to treat seizures is drawing significant interest across the industry.
Lupin receives USFDA approval for generic Brivaracetam Oral Solution to treat seizures, initiating its U.S. market launch.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Luxury brand sells ‘iron burn’ shirt for Rs 1 Lakh, leaves netizens in splits
- ‘College GameDay’ Announces Celebrity Guest Picker for UNC-Duke Rivalry Game
- 'Ghostbusters' actress Jennifer Runyon passes away at 65 after 'long and arduous journey'
- China's Strategic Shift: Energy and Diplomacy Over Support for Iran
Source: Original →